Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Paesmans

Showing results (131-140 of 187) with videos related to

Pageof 19
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
A phase II randomised trial comparing the cisplatin-etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancerJ P Sculier, J J Lafitte, J Lecomte, et al.
International Journal of Oncology|December 5, 2003
Correlation between complete response to anthracycline-based chemotherapy and topoisomerase II-alpha gene amplification and protein overexpression in locally advanced/metastatic breast cancerF Cardoso, V Durbecq, D Larsimont, et al.
Cancer|August 10, 2000
Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 yearsM Paesmans, J P Sculier, J Lecomte, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 7, 2008
The use of low-energy laser (LEL) for the prevention of chemotherapy- and/or radiotherapy-induced oral mucositis in cancer patients: results from two prospective studiesM T Genot-Klastersky, J Klastersky, F Awada, et al.
Lung Cancer (Amsterdam, Netherlands)|June 19, 2012
Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): a phase II randomised study by the European Lung Cancer Working PartyT Berghmans, J J Lafitte, V Giner, et al.
Maturitas|November 19, 2017
Distribution of clinical risk factors for fracture in a Brussels cohort of postmenopausal women: The FRISBEE study and comparison with other major cohort studiesS I Cappelle, I Ramon, C Dekelver, et al.
British Journal of Cancer|December 15, 2004
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysisC Mascaux, N Iannino, B Martin, et al.
Annales D'Endocrinologie|January 1, 1997
[Belgian registry of thyroid cancer. Preliminary epidemiological characteristics revealed by a retrospective study (1988-1995). Belgian Thyroid Cancer Study Group]M Meurisse, N Claeys, M Paesmans, et al.
The European Respiratory Journal|June 10, 2010
Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II studyA Scherpereel, T Berghmans, J J Lafitte, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 5, 2020
Osteoporosis treatment gap in a prospective cohort of volunteer womenL Iconaru, C Smeys, F Baleanu, et al.
Pageof 19

Showing results (131-140 of 187) with videos related to

Sort By:
Pageof 19
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
A phase II randomised trial comparing the cisplatin-etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancerJ P Sculier, J J Lafitte, J Lecomte, et al.
International Journal of Oncology|December 5, 2003
Correlation between complete response to anthracycline-based chemotherapy and topoisomerase II-alpha gene amplification and protein overexpression in locally advanced/metastatic breast cancerF Cardoso, V Durbecq, D Larsimont, et al.
Cancer|August 10, 2000
Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 yearsM Paesmans, J P Sculier, J Lecomte, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 7, 2008
The use of low-energy laser (LEL) for the prevention of chemotherapy- and/or radiotherapy-induced oral mucositis in cancer patients: results from two prospective studiesM T Genot-Klastersky, J Klastersky, F Awada, et al.
Lung Cancer (Amsterdam, Netherlands)|June 19, 2012
Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): a phase II randomised study by the European Lung Cancer Working PartyT Berghmans, J J Lafitte, V Giner, et al.
Maturitas|November 19, 2017
Distribution of clinical risk factors for fracture in a Brussels cohort of postmenopausal women: The FRISBEE study and comparison with other major cohort studiesS I Cappelle, I Ramon, C Dekelver, et al.
British Journal of Cancer|December 15, 2004
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysisC Mascaux, N Iannino, B Martin, et al.
Annales D'Endocrinologie|January 1, 1997
[Belgian registry of thyroid cancer. Preliminary epidemiological characteristics revealed by a retrospective study (1988-1995). Belgian Thyroid Cancer Study Group]M Meurisse, N Claeys, M Paesmans, et al.
The European Respiratory Journal|June 10, 2010
Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II studyA Scherpereel, T Berghmans, J J Lafitte, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 5, 2020
Osteoporosis treatment gap in a prospective cohort of volunteer womenL Iconaru, C Smeys, F Baleanu, et al.
Pageof 19